• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Congenital Hemangiomas: When -- and How -- to Excise (Video: 3:30 minutes)


Congenital hemangiomas that grow rapidly or that threaten a vital organ may now be treated with oral propranol or topical timolol. Details here.

Congenital hemangiomas generally undergo spontaneous resolution; 90% disappear by the time a child reaches age 10. However, removal is indicated if these lesions are growing and/or threatening vital organs.

Treatment options include:
. Oral steroids
. Oral propranolol
. Topical timolol 

Kasabach-Merritt syndrome involves the presence of a large congenital hemangioma that destroys platelets and consumes coagulation factors. These lesions appear in the early postpartum period; affected children often have a bleeding diathesis.
Treatment includes:

. Correcting the coagulopathy

. Addressing the tumor (via surgery, embolization, oral propranolol, oral steroids)      

For more webinar videos, click here.

Related Videos
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
© 2024 MJH Life Sciences

All rights reserved.